Crossmark

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials

Crossref DOI link: https://doi.org/10.1186/s12951-018-0339-0

Published Online: 2018-02-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gdowski, Andrew

Johnson, Kaitlyn

Shah, Sunil

Gryczynski, Ignacy

Vishwanatha, Jamboor

Ranjan, Amalendu https://orcid.org/0000-0002-3641-7751
Funding

Funding for this research was provided by:

Cancer Prevention and Research Institute of Texas (RP170301)

Foundation for the National Institutes of Health (R21CA194295)

Foundation for the National Institutes of Health (P20MD006882)

Institutional Seed Grant (RI10076)
More Information

Article History

Received: 6 September 2017

Accepted: 1 February 2018

First Online: 12 February 2018